Floadia has announced raising about $7 million in Series D funding, while Abu Dhabi’s Eclat Health Solutions has fully acquired the health information management division of Excite Health Partners.
Cypress Capital, Inabata co-lead Floadia’s Series D funding
Floadia, a Tokyo-based embedded flash memory developer, has announced raising a total of 1.05 billion yen (about $7 million) in a Series D funding round anchored by Hong Kong investment company Cypress Capital and Osaka-based investor Inabata & Co.
Government-owned Japan Finance Corporation also provided 200 million yen in venture debt in the said round, according to the announcement.
The Japanese company, established in 2011, is in the business of licensing the processes and circuit design necessary for manufacturing flash memory. It said it will use the fresh funds to beef up marketing activities for promoting its current primary business.
The Series D funding round brings the total funds raised by Floadia to date to about 4.95 billion yen ($33 million), including the approximately 3.9 billion yen it received from Japanese government fund INCJ.
Eclat Health acquires HIM unit of Excite Health Partners
Eclat Health Solutions, a portfolio company of private equity firm Gulf Capital, has acquired the health information management (HIM) division of Excite Health Partners for an undisclosed amount.
In a statement, Gulf Capital said the acquisition marks the third buyout deal for its US Revenue Cycle Management Platform, which further expands its services across the US healthcare industry.
The deal is also the second bolt-on acquisition announced over the last two weeks by Gulf Capital, following the recent acquisition by its intellectual property firm CWB of Hahn &Hahn in Africa.
DealStreetAsia reported in February that Gulf Capital, which invests from the GCC to the rest of Asia, was in the market to raise capital for its control-growth buyout vehicle GC Equity Partners IV. The firm targets about $750 million for the vehicle.